Advanced Filters
noise

Autonomic Nervous System Clinical Trials

A listing of Autonomic Nervous System medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 198 clinical trials
S Sana Bashir, DPT, MS-CPPT,PHD*

Autogenic Inhibition Versus Reciprocal Inhibition Muscle Energy Techniques Effect on Swimming Performance on Swimmers With Scapular Dyskinesis

Swimming can cause shoulder pain due to scapular dyskinesis. Proper scapula movement is necessary for efficient swimming strokes and to avoid injury. Studying the effects of autogenic and reciprocal inhibition muscle energy techniques on swimmers with scapular dyskinesis can lead to effective interventions and reduce shoulder injuries

18 - 30 years of age Both Phase N/A
H Hamza Azeem, BBA

Effect of Scapular Stabilization Excercise With Pectoralis Minor Stretching in Ballers Having Scapular Dyskinesia

The study is randomized and single -blinded. Ethical approval is taken from ethical committee of Riphah International university Lahore. participant selected through non probability convenience sampling technique on 26 fast bowlers which further players were randomly divided into two groups, group A (Experimental group) and group B (Control group), having …

21 - 23 years of age Male Phase N/A
H Hasan Cellatoglu

Effect of Proprioceptive Neuromuscular Facilitation Techniques on Elderly People With Scapular Disposition

Proprioceptive neuromuscular facilitation (PNF) has been defined as a comprehensive rehabilitation approach focusing on a motor learning effect, especially in the elderly. Therefore, PNF can be an effective treatment method for our purpose which is to analyze if PNF techniques improve balance and gait characteristics in elderly with scapular disposition …

65 - 74 years of age Both Phase N/A

Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy

The primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in participants aged 6 to 70 years who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.

6 - 70 years of age Both Phase 3
K Kristina Simonyan, MD, PhD

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

This research involves retrospective and prospective studies for clinical validation of a DystoniaNet deep learning platform for the diagnosis of isolated dystonia.

- 100 years of age Both Phase N/A
K Kenzie Miller

Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes

The study is being conducted to validate the feasibility of remote assessment of Tardive Dyskinesia.

18 - 100 years of age Both Phase N/A
H Huafang Li

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

This is a multicenter, randomized, double-blind, placebo-controlled parallel-group trial to evaluate the safety, tolerability, preliminary efficacy and PK characteristics of multiple doses of LPM3770164 sustained-release tablets in TD patients.

18 - 64 years of age Both Phase 1/2
H Huafang Li

Safety, Tolerability and Pharmacokinetic of Multiple-ascending Doses of LPM3770164 in Healthy Subjects

This is a single-center, randomized, double-blind, placebo-controlled, multiple-ascending doses trial to evaluate the safety, tolerability and pharmacokinetic of LPM3770164 sustained-release tablets orally administered in healthy subjects under fasting state, providing the rationale information for later clinical trials.

18 - 45 years of age Both Phase 1
J Jessica N Bentley, MD

Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders

The purpose of this study is to investigate the brain activity associated with motor and non-motor symptoms of movement disorders, including Parkinson's disease (PD) and essential tremor. These movement disorders commonly have significant non-motor features, such as depression, cognitive and memory impairment, decreased attention, speech and language disturbances, and slower …

18 - 100 years of age Both Phase N/A
Y Yongqin Xiong, MD

MRgFUS Thalamotomy for Therapy-Resistant Tremor-related Disease With Low SDR Value

A study to evaluate the effectiveness and safety of ExAblate transcranial MRgFUS Thalamotomy treatment of medication refractory tremor-related diseases subjects with low skull density ratio (SDR) value. Essential tremor (ET) and Parkinson disease (PD) are the most prevalent tremor disorders. ET, considered as a pure tremor disease, is characterized by …

22 - 99 years of age Both Phase N/A

Rewrite in simple language using AI